Modified low ratio ketogenic therapy in the treatment of adults with super-refractory status epilepticus.

Neha KaulJudy NationJoshua Laing John-Paul Nicolo Adam M Deane Andrew A Udy Patrick Kwan Terence J O'Brien

Published in: JPEN. Journal of parenteral and enteral nutrition (2022)

Despite the challenge in maintaining ketosis during critical illness, low ratio 2:1 ketogenic therapy incorporating medium chain triglycerides is tolerable for adults with SRSE. Further studies are required to determine the optimal timing, nutrition prescription and duration of ketogenic therapy for SRSE treatment.

Keyphrases

stem cells
mesenchymal stem cells